Ramy Riad: Advancing Plasma-Derived Therapies Through Partnership
Ramy Riad, President of Plasma-Derived Therapies Business Unit at Takeda, shared a post on LinkedIn:
“Wrapping up a productive first day at IPPC 2026, hosted by Plasma Protein Therapeutics Association (PPTA), with a real sense of momentum.
This year’s theme — ‘Resilience, Reach and Responsibility’ — perfectly captures the leadership imperative facing our industry.
No single organization can sustain the plasma ecosystem alone.
It requires long‑term partnerships and shared responsibility across the value chain.
Today’s conversations reinforced how essential collaboration is to protect access for the patients who depend on plasma-derived therapies.
Looking forward to the sessions ahead and to connecting with fellow leaders shaping the future of plasma.”
Stay updated with Hemostasis Today.
-
May 2, 2026, 15:08Ethology and Treatment of Iron Deficiency – Sociedad Iberoamericana de Patient Blood Management
-
May 2, 2026, 14:56Navigating Surgical Bleed Risk in Anticoagulation Management – Thrombosis Canada
-
May 2, 2026, 14:42Gareth Owens: EACTS Aortic Webinar on Heritable Thoracic Aortic Disease and Marfan Syndrome
-
May 2, 2026, 14:39William Wallace: Your Nerves Can Be Damaged Before Your Blood Shows It
-
May 2, 2026, 14:33Alan Nurden: Translating Advances into Access in Rare Platelet Disorder Management
-
May 2, 2026, 14:28Rahul Saha: A Rare Link Between Hypothyroidism and Budd Chiari Syndrome
-
May 2, 2026, 14:12Burhan Ullah: Blood Components Overview
-
May 2, 2026, 14:09Abid Ur Rahman: Platelet Disorders and Laboratory Findings
-
May 2, 2026, 14:04Natalia Barajas Castrellon: FRONTIER2 Results Show Potential for Prophylactic Therapy in Hemophilia A